Literature DB >> 8624811

An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501.

K J Smith1, S W Reid, D I Stuart, A J McMichael, E Y Jones, J I Bell.   

Abstract

The crystal structure of the human major histocompatibility complex class I B allele HLA B*3501 complexed with the 8-mer peptide epitope HIV1 Nef 75-82 (VPLRPMTY) has been determined at 2.0 angstrom resolution. Comparison with the crystal structure of the closely related allele HLA B*5301 reveals the structural basis for the tyrosine specificity of the B*3501 F pocket. The structure also reveals a novel conformation of the 8-mer peptide within the binding groove. The positions of the peptide N and C termini are nonstandard, but the classic pattern of hydrogen bonding to nonpolymorphic MHC class I residues is maintained, at the N terminus by addition of a water molecule, and at the C terminus by a substantial shift in the alpha 2 helix.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8624811     DOI: 10.1016/s1074-7613(00)80429-x

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  46 in total

1.  Function-related regulation of the stability of MHC proteins.

Authors:  A Simon; Z s Dosztányi; E Rajnavölgyi; I Simon
Journal:  Biophys J       Date:  2000-11       Impact factor: 4.033

2.  Structure-based prediction of binding peptides to MHC class I molecules: application to a broad range of MHC alleles.

Authors:  O Schueler-Furman; Y Altuvia; A Sette; H Margalit
Journal:  Protein Sci       Date:  2000-09       Impact factor: 6.725

3.  Predicting sequences and structures of MHC-binding peptides: a computational combinatorial approach.

Authors:  J Zen; H R Treutlein; G B Rudy
Journal:  J Comput Aided Mol Des       Date:  2001-06       Impact factor: 3.686

4.  Class I molecules with similar peptide-binding specificities are the result of both common ancestry and convergent evolution.

Authors:  Alessandro Sette; John Sidney; Brian D Livingston; John L Dzuris; Claire Crimi; Christopher M Walker; Scott Southwood; Edward J Collins; Austin L Hughes
Journal:  Immunogenetics       Date:  2003-02-14       Impact factor: 2.846

5.  Conformational flexibility of the MHC class I alpha1-alpha2 domain in peptide bound and free states: a molecular dynamics simulation study.

Authors:  Martin Zacharias; Sebastian Springer
Journal:  Biophys J       Date:  2004-10       Impact factor: 4.033

6.  Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire.

Authors:  David A Ostrov; Barry J Grant; Yuri A Pompeu; John Sidney; Mikkel Harndahl; Scott Southwood; Carla Oseroff; Shun Lu; Jean Jakoncic; Cesar Augusto F de Oliveira; Lun Yang; Hu Mei; Leming Shi; Jeffrey Shabanowitz; A Michelle English; Amanda Wriston; Andrew Lucas; Elizabeth Phillips; Simon Mallal; Howard M Grey; Alessandro Sette; Donald F Hunt; Soren Buus; Bjoern Peters
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

7.  Conformational melding permits a conserved binding geometry in TCR recognition of foreign and self molecular mimics.

Authors:  Oleg Y Borbulevych; Kurt H Piepenbrink; Brian M Baker
Journal:  J Immunol       Date:  2011-01-31       Impact factor: 5.422

8.  Peptide modulation of class I major histocompatibility complex protein molecular flexibility and the implications for immune recognition.

Authors:  William F Hawse; Brian E Gloor; Cory M Ayres; Kevin Kho; Elizabeth Nuter; Brian M Baker
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

9.  Self and viral peptides can initiate lysis by autologous natural killer cells.

Authors:  O Mandelboim; S B Wilson; M Valés-Gómez; H T Reyburn; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

10.  Assembly and intracellular trafficking of HLA-B*3501 and HLA-B*3503.

Authors:  Vilasack Thammavongsa; Malinda Schaefer; Tracey Filzen; Kathleen L Collins; Mary Carrington; Naveen Bangia; Malini Raghavan
Journal:  Immunogenetics       Date:  2009-12       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.